{"id":"https://openalex.org/W2139591966","doi":"https://doi.org/10.3310/hta10090","title":"Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation","display_name":"Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2139591966","doi":"https://doi.org/10.3310/hta10090","mag":"2139591966","pmid":"https://pubmed.ncbi.nlm.nih.gov/16545208"},"language":"en","primary_location":{"id":"doi:10.3310/hta10090","doi":"https://doi.org/10.3310/hta10090","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta10090","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2001307","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139591966"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://njl-admin.nihr.ac.uk/document/download/2001307","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054990256","display_name":"Caroline Main","orcid":"https://orcid.org/0000-0002-9686-3438","observed_orcids":["https://orcid.org/0000-0002-9686-3438"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Main","raw_affiliation_strings":["Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046482252","display_name":"Laura Bojke","orcid":"https://orcid.org/0000-0001-7921-9109","observed_orcids":["https://orcid.org/0000-0001-7921-9109"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Bojke","raw_affiliation_strings":["Centre for Health Economics, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004026303","display_name":"Susan C. Griffin","orcid":"https://orcid.org/0000-0003-2188-8400","observed_orcids":["https://orcid.org/0000-0003-2188-8400"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Griffin","raw_affiliation_strings":["Centre for Health Economics, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043297254","display_name":"Gill Norman","orcid":"https://orcid.org/0000-0002-3972-5733","observed_orcids":["https://orcid.org/0000-0002-3972-5733"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Norman","raw_affiliation_strings":["Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Barbieri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Barbieri","raw_affiliation_strings":["Economic and Health Research Centre, Universitat Pompeu Fabra, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Economic and Health Research Centre, Universitat Pompeu Fabra, Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L Mather","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Mather","raw_affiliation_strings":["Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089629100","display_name":"Dan Stark","orcid":"https://orcid.org/0000-0002-6172-733X","observed_orcids":["https://orcid.org/0000-0002-6172-733X"]},"institutions":[{"id":"https://openalex.org/I2800495676","display_name":"Bradford Royal Infirmary","ror":"https://ror.org/01ck0pr88","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800495676","https://openalex.org/I4210166758"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D Stark","raw_affiliation_strings":["Department of Oncology, Bradford Royal Infirmary, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Bradford Royal Infirmary, UK","institution_ids":["https://openalex.org/I2800495676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049679176","display_name":"Stephen Palmer","orcid":"https://orcid.org/0000-0002-7268-2560","observed_orcids":["https://orcid.org/0000-0002-7268-2560"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Palmer","raw_affiliation_strings":["Centre for Health Economics, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029658912","display_name":"Robert P. Riemsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R Riemsma","raw_affiliation_strings":["Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029658912"],"corresponding_institution_ids":["https://openalex.org/I52099693"],"apc_list":null,"apc_paid":null,"fwci":2.4166,"has_fulltext":true,"cited_by_count":160,"citation_normalized_percentile":{"value":0.91919192,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"10","issue":"9","first_page":"1","last_page":"132. iii"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pegylated-liposomal-doxorubicin","display_name":"pegylated liposomal doxorubicin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8420000076293945},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.6899999976158142},{"id":"https://openalex.org/keywords/platinum-sensitive-ovarian-cancer","display_name":"platinum-sensitive ovarian cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.7350000143051147},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.722000002861023},{"id":"https://openalex.org/keywords/survival-time","display_name":"survival time","score":0.5370000004768372},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.41100001335144043},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.5680000185966492},{"id":"https://openalex.org/keywords/clinical-effectiveness","display_name":"clinical effectiveness","score":0.45899999141693115},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.821430504322052},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.6703105568885803},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.5396184921264648},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5284421443939209},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.5226290225982666},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.5102736949920654},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46770307421684265},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.46369990706443787},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.295274555683136},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.2729528248310089},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20591771602630615},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10436812043190002},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0889911949634552},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3310/hta10090","doi":"https://doi.org/10.3310/hta10090","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta10090","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2001307","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},{"id":"pmid:16545208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16545208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health technology assessment (Winchester, England)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c5268ec84cd94d4fb72317429e5e734a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c5268ec84cd94d4fb72317429e5e734a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Technology Assessment, Vol 10, Iss 9 (2006)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3310/hta10090","doi":"https://doi.org/10.3310/hta10090","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta10090","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2001307","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[{"id":"https://openalex.org/G1993789008","display_name":null,"funder_award_id":"04/03/01","funder_id":"https://openalex.org/F4320334661","funder_display_name":"Health Technology Assessment Programme"},{"id":"https://openalex.org/G7376281158","display_name":null,"funder_award_id":"04/03/01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320321040","display_name":"National Science Council","ror":"https://ror.org/02kv4zf79"},{"id":"https://openalex.org/F4320334661","display_name":"Health Technology Assessment Programme","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139591966.pdf","grobid_xml":"https://content.openalex.org/works/W2139591966.grobid-xml"},"referenced_works_count":172,"referenced_works":["https://openalex.org/W51288761","https://openalex.org/W92981104","https://openalex.org/W168464628","https://openalex.org/W187925780","https://openalex.org/W199748268","https://openalex.org/W308493407","https://openalex.org/W1491019057","https://openalex.org/W1513512556","https://openalex.org/W1548467005","https://openalex.org/W1595046345","https://openalex.org/W1814848861","https://openalex.org/W1852106026","https://openalex.org/W1863225814","https://openalex.org/W1878670617","https://openalex.org/W1882099583","https://openalex.org/W1913802169","https://openalex.org/W1942558153","https://openalex.org/W1960327677","https://openalex.org/W1964232315","https://openalex.org/W1966925237","https://openalex.org/W1967106710","https://openalex.org/W1969006368","https://openalex.org/W1969409726","https://openalex.org/W1969916216","https://openalex.org/W1973221118","https://openalex.org/W1973461617","https://openalex.org/W1977534258","https://openalex.org/W1978799196","https://openalex.org/W1979355909","https://openalex.org/W1980084959","https://openalex.org/W1980762586","https://openalex.org/W1984413235","https://openalex.org/W1985384141","https://openalex.org/W1987194064","https://openalex.org/W1987862403","https://openalex.org/W1989331806","https://openalex.org/W1989495864","https://openalex.org/W1992683273","https://openalex.org/W1993880164","https://openalex.org/W1994689333","https://openalex.org/W1995366276","https://openalex.org/W1996465736","https://openalex.org/W1998617484","https://openalex.org/W1999789157","https://openalex.org/W1999957443","https://openalex.org/W2001632038","https://openalex.org/W2002081615","https://openalex.org/W2002177893","https://openalex.org/W2008293816","https://openalex.org/W2013754529","https://openalex.org/W2014803691","https://openalex.org/W2015436202","https://openalex.org/W2016105809","https://openalex.org/W2016179096","https://openalex.org/W2016235740","https://openalex.org/W2016576284","https://openalex.org/W2019510314","https://openalex.org/W2021402729","https://openalex.org/W2025210272","https://openalex.org/W2027006764","https://openalex.org/W2028855863","https://openalex.org/W2029918359","https://openalex.org/W2035122895","https://openalex.org/W2038320131","https://openalex.org/W2041960461","https://openalex.org/W2043055146","https://openalex.org/W2043651931","https://openalex.org/W2046914153","https://openalex.org/W2047731572","https://openalex.org/W2049281357","https://openalex.org/W2049410465","https://openalex.org/W2051970328","https://openalex.org/W2052521108","https://openalex.org/W2052814236","https://openalex.org/W2053079473","https://openalex.org/W2053655472","https://openalex.org/W2055272681","https://openalex.org/W2055832348","https://openalex.org/W2055890800","https://openalex.org/W2056018456","https://openalex.org/W2061382057","https://openalex.org/W2061490171","https://openalex.org/W2061699491","https://openalex.org/W2065071195","https://openalex.org/W2067383190","https://openalex.org/W2067902232","https://openalex.org/W2070775228","https://openalex.org/W2079537409","https://openalex.org/W2080042606","https://openalex.org/W2083207094","https://openalex.org/W2083840168","https://openalex.org/W2090527319","https://openalex.org/W2091121711","https://openalex.org/W2091941736","https://openalex.org/W2096491215","https://openalex.org/W2096883889","https://openalex.org/W2097105130","https://openalex.org/W2098933230","https://openalex.org/W2102817068","https://openalex.org/W2103663755","https://openalex.org/W2104284587","https://openalex.org/W2106203584","https://openalex.org/W2108703276","https://openalex.org/W2111041730","https://openalex.org/W2111619241","https://openalex.org/W2111922520","https://openalex.org/W2113235032","https://openalex.org/W2113587402","https://openalex.org/W2116567336","https://openalex.org/W2116996913","https://openalex.org/W2118851499","https://openalex.org/W2122945204","https://openalex.org/W2129258132","https://openalex.org/W2130761965","https://openalex.org/W2130787156","https://openalex.org/W2131097924","https://openalex.org/W2133894270","https://openalex.org/W2134032079","https://openalex.org/W2134527552","https://openalex.org/W2134947875","https://openalex.org/W2141505363","https://openalex.org/W2143106165","https://openalex.org/W2143425970","https://openalex.org/W2145366428","https://openalex.org/W2145827555","https://openalex.org/W2146239695","https://openalex.org/W2147762911","https://openalex.org/W2150927382","https://openalex.org/W2151050516","https://openalex.org/W2152021094","https://openalex.org/W2152246203","https://openalex.org/W2153291245","https://openalex.org/W2153557259","https://openalex.org/W2158888710","https://openalex.org/W2161084617","https://openalex.org/W2161236201","https://openalex.org/W2167571044","https://openalex.org/W2167659614","https://openalex.org/W2168890936","https://openalex.org/W2169495405","https://openalex.org/W2170845869","https://openalex.org/W2172231059","https://openalex.org/W2239815468","https://openalex.org/W2319708900","https://openalex.org/W2325521096","https://openalex.org/W2327253023","https://openalex.org/W2332006577","https://openalex.org/W2342093135","https://openalex.org/W2396634817","https://openalex.org/W2403562875","https://openalex.org/W2404188165","https://openalex.org/W2405845947","https://openalex.org/W2413290086","https://openalex.org/W2414678127","https://openalex.org/W2414752518","https://openalex.org/W2443876015","https://openalex.org/W2461434215","https://openalex.org/W2493886745","https://openalex.org/W2522899364","https://openalex.org/W2552085674","https://openalex.org/W2604144817","https://openalex.org/W2781052640","https://openalex.org/W2781844049","https://openalex.org/W2781883541","https://openalex.org/W2921228809","https://openalex.org/W2947096539","https://openalex.org/W4205434326","https://openalex.org/W4238103718","https://openalex.org/W4249893914","https://openalex.org/W4250808545","https://openalex.org/W4285719527","https://openalex.org/W4387083403"],"related_works":["https://openalex.org/W2056932109","https://openalex.org/W2994778322","https://openalex.org/W3086674581","https://openalex.org/W2083840168","https://openalex.org/W3026499365","https://openalex.org/W2023096794","https://openalex.org/W2111922520","https://openalex.org/W2076345229","https://openalex.org/W1987194064","https://openalex.org/W2019510314"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1,1110],"examine":[2],"the":[3,32,66,78,95,106,109,112,118,133,147,185,206,214,219,255,261,264,303,307,313,317,332,342,358,368,383,393,397,410,414,417,438,454,466,478,484,491,494,504,512,528,537,546,557,560,589,598,602,605,608,640,661,720,739,749,756,769,838,879,927,948,955,958,970,997,1002,1010,1016,1023,1034,1043,1047,1071,1082,1085,1112],"clinical":[4,67,817,1105],"effectiveness":[5,68,1113],"and":[6,20,62,72,74,83,90,117,164,169,201,233,236,252,295,319,337,347,365,374,379,421,445,462,540,548,584,601,622,633,650,664,743,755,760,781,845,852,897,943,957,961,991,1001,1065,1075],"cost-effectiveness":[7,79,134,308,333,343,399,475,558,1007],"of":[8,11,37,69,77,80,108,120,123,143,192,216,230,260,312,325,334,344,360,370,416,486,493,517,559,563,610,705,751,753,758,776,808,819,832,876,922,954,967,996,1018,1025,1049,1073,1084,1107,1114],"intravenous":[9,298],"formulations":[10],"topotecan":[12,71,82,198,336,346,404,711,990,1064],"monotherapy,":[13,648,993,1040],"pegylated":[14],"liposomal":[15],"doxorubicin":[16,232],"hydorocholoride":[17],"(PLDH)":[18],"monotherapy":[19,390,621,629,659,674,1054],"paclitaxel":[21,73,200,226,237,282,289,348,389,420,429,509,521,620,851,898,992,1039,1053,1066,1074,1131],"used":[22,128,150,267],"alone":[23],"or":[24,34,712],"in":[25,132,184,254,257,263,275,328,413,437,453,465,499,527,536,545,573,723,734,764,774,815,910,920,994,1103,1132],"combination":[26,229,582,652,684,854,861,1072,1115,1133],"with":[27,161,176,213,428,511,520,616,672,687,697,709,824,860,869,931,940,952,989,1042,1052,1063,1095,1134],"a":[28,170,228,323,702,829,870,891,1118,1127,1135,1143],"platinum-based":[29,239,243,1136],"compound":[30],"for":[31,57,65,306,386,425,477,503,506,566,669,682,850,1009,1033,1036],"second-line":[33,798],"subsequent":[35],"treatment":[36,378,564,570,708,859,868,930],"advanced":[38,166],"ovarian":[39,167],"cancer.":[40],"DATA":[41],"SOURCES:":[42],"Electronic":[43],"databases":[44,54],"covering":[45],"publication":[46],"years":[47],"2000-4.":[48],"Company":[49],"submissions.":[50,98],"REVIEW":[51],"METHODS:":[52],"Seventeen":[53],"were":[55,87,94,139,149,182,194,222,224,250,278,402,419,481,594,624,646,848,1013],"searched":[56],"randomised":[58],"controlled":[59],"trials":[60,187,209,249,277,818,1106],"(RCTs)":[61],"systematic":[63],"reviews":[64],"PLDH,":[70,81,335,345,577,710],"economic":[75,314],"evaluations":[76],"paclitaxel.":[84,204,338,713],"Selected":[85],"studies":[86,301,330],"quality":[88,122,752],"assessed":[89,183,223,274,341],"data":[91,373,497,1028],"extracted,":[92],"as":[93,350,392,946],"three":[96,158,186,656,721,770,914],"company":[97],"A":[99,246],"new":[100,820,1108],"model":[101,575],"was":[102,127,266,354,405,430,450,522,660,675,689,701,716,828,1055,1059],"developed":[103],"to":[104,129,356,483,588,596,707,725,947,963,974,977,985,1015,1078],"assess":[105,1111],"costs":[107,632],"alternative":[110,375],"treatments,":[111],"differential":[113],"mean":[114],"survival":[115,741,834,843],"duration":[116],"impact":[119,359],"health-related":[121],"life.":[124],"Monte-Carlo":[125],"simulation":[126],"reflect":[130],"uncertainty":[131],"results.":[135,514,1045],"RESULTS:":[136],"Nine":[137],"RCTs":[138],"identified.":[140],"In":[141,205,382,874],"five":[142],"these":[144,156,276,611,638,655,907,965],"trials,":[145,607],"both":[146,162,190],"comparators":[148,180,220,262,273,565,722,729,771,909,915,956],"within":[151],"their":[152,735,777,923],"licensed":[153,270],"indications.":[154],"Of":[155,654],"five,":[157],"included":[159,174,189,211,253,814,1102],"participants":[160,175,193,212,696,823,1094],"platinum-resistant":[163,547,698,1096],"platinum-sensitive":[165,177,217,364,455,538,567,825,1069],"cancer,":[168],"further":[171,207,247,816,892,1104],"two":[172,208,291,908],"only":[173],"disease.":[178],"The":[179,272,310,423,448,474,515,551,569,667,680,728,840,913,1006],"that":[181,188,210,221,593,642,748,789,805,858,882,894,900,939,1093,1126,1129],"subtypes":[191],"PLDH":[195,202,426,507,518,623,883,896,932,983,1037,1050,1058,1140],"versus":[196,199,203,227,241,280,285,297,508,1038,1138],"topotecan,":[197,578,941],"subtype":[215],"disease,":[218],"single-agent":[225,871,877,1119,1139],"cyclophosphamide,":[231],"cisplatin":[234],"(CAP)":[235],"plus":[238],"chemotherapy":[240],"conventional":[242],"therapy":[244,583,685,862,1116,1137],"alone.":[245],"four":[248],"identified":[251,322],"review":[256,311],"which":[258],"one":[259],"trial":[265,372,488,496,893,1020,1027,1128],"outside":[268],"its":[269],"indication.":[271],"oxaliplatin":[279],"paclitaxel,":[281],"given":[283],"weekly":[284],"every":[286],"3":[287],"weeks,":[288],"at":[290],"different":[292,606],"dose":[293],"levels":[294],"oral":[296],"topotecan.":[299,888],"Four":[300],"met":[302],"inclusion":[304,369,485,1017],"criteria":[305],"review.":[309],"evidence":[315,600,880,1086],"from":[316,553,812,890,1100],"literature":[318],"industry":[320],"submissions":[321],"number":[324],"significant":[326,904],"limitations":[327],"existing":[329],"assessing":[331],"Analysis":[339,387,554],"1":[340],"administered":[349],"monotherapies.":[351],"Sensitivity":[352],"analysis":[353,480,1012],"undertaken":[355],"explore":[357],"patient":[361,440,530,766,780,942,999],"heterogeneity":[362,603],"(e.g.":[363],"platinum-resistant/refractory":[366],"patients),":[367],"additional":[371,487,495,981,1019,1026],"assumptions":[376],"regarding":[377,797],"monitoring":[380],"costs.":[381],"base-case":[384,479,513,1011,1044],"results":[385,476,492,552,612,1008,1024],"1,":[388],"emerged":[391],"cheapest":[394],"treatment.":[395],"When":[396],"incremental":[398],"ratios":[400],"(ICERs)":[401],"estimated,":[403],"dominated":[406,626],"by":[407,627],"PLDH.":[408,422],"Hence":[409],"options":[411,571],"considered":[412,572],"estimation":[415],"ICERs":[418],"ICER":[424,449,505,516,668,681,1035,1048],"compared":[427,510,519,671,686,895,988,1041,1051,1062,1130],"pound":[431,458,470,523,532,541,676,690,978],"7033":[432],"per":[433,460,472,525,534,543,678,692,980],"quality-adjusted":[434],"life-year":[435],"(QALY)":[436],"overall":[439,529,726,998],"population":[441,539,1000],"(comprising":[442],"platinum-sensitive,":[443],"-refractory":[444,549],"-resistant":[446],"patients).":[447],"more":[451,865,885,936],"favourable":[452,464,501,842,1031],"group":[456,468,807],"(":[457,469],"5777":[459],"QALY)":[461],"less":[463,500,590,1030,1056],"platinum-refractory/resistant":[467],"9555":[471],"QALY).":[473],"sensitive":[482,1014],"data.":[489,1021],"Incorporating":[490,1022],"resulted":[498],"estimates":[502,1032],"20,620":[524],"QALY":[526,535,544],"population,":[531],"16,183":[533],"26,867":[542],"population.":[550],"2":[555],"explored":[556],"full":[561],"range":[562,831],"patients.":[568],"this":[574,765,806,911],"comprised":[576],"paclitaxel-monotherapy,":[579],"CAP,":[580],"paclitaxel/platinum":[581],"platinum":[585,628,647,658,673,853,1076],"monotherapy.":[586,1067],"Owing":[587],"robust":[591],"approaches":[592],"employed":[595],"synthesise":[597],"available":[599],"between":[604,719,906],"reliability":[609],"should":[613,790],"be":[614,791,803,864,935,986,1079,1091,1124,1142],"interpreted":[615],"some":[617],"caution.":[618],"Topotecan,":[619],"all":[625],"(i.e.":[630],"higher":[631],"lower":[634],"QALYs).":[635],"After":[636],"excluding":[637],"alternatives,":[639,657],"treatments":[641],"remained":[643],"under":[644],"consideration":[645],"CAP":[649,670,688],"paclitaxel-platinum":[651,683],"therapy.":[653,799,855],"least":[662,665],"costly":[663],"effective.":[666],"16,421":[677],"QALY.":[679,693],"20,950":[691],"CONCLUSIONS:":[694],"For":[695,822,1068],"disease":[699,826,1097],"there":[700,715,827,901],"low":[703,740],"probability":[704],"response":[706,744,846],"Furthermore,":[714],"little":[717],"difference":[718,905],"relation":[724],"survival.":[727],"did,":[730,916],"however,":[731,917],"differ":[732,918],"considerably":[733],"toxicity":[736,761,778,924],"profiles.":[737],"Given":[738],"times":[742,835,844],"rates,":[745],"it":[746,1089,1122],"appears":[747,984,1077],"maintenance":[750],"life":[754],"control":[757],"symptoms":[759],"are":[762,795,966],"paramount":[763],"group.":[767],"As":[768],"differed":[772],"significantly":[773,919],"terms":[775,875,921,995],"profiles,":[779],"physician":[782,944],"choice":[783,945],"is":[784,884,902,972],"also":[785,802],"an":[786],"important":[787],"element":[788],"addressed":[792],"when":[793],"decisions":[794],"made":[796],"It":[800],"can":[801,1090,1123],"suggested":[804,1092,1125],"patients":[809],"may":[810,863,933,1098],"benefit":[811,1099],"being":[813,1101],"drugs.":[821,1109],"considerable":[830],"median":[833],"observed":[836,849],"across":[837,926],"trials.":[839,928],"most":[841],"rates":[847],"This":[856],"suggests":[857,881,899],"beneficial":[866,937],"than":[867,887,938],"chemotherapeutic":[872],"regimen.":[873],"compounds,":[878],"effective":[886],"Evidence":[889],"no":[903],"trial.":[912],"profiles":[925],"Although":[929,1046],"therefore":[934],"potential":[949],"toxicities":[950],"associated":[951],"each":[953],"patient's":[959],"ability":[960],"willingness":[962],"tolerate":[964],"importance.":[968],"Assuming":[969],"NHS":[971],"willing":[973],"pay":[975],"up":[976],"20,000-40,000":[979],"QALY,":[982],"cost-effective":[987,1061],"main":[1003],"subgroups":[1004],"considered.":[1005],"gave":[1029],"favourable,":[1057],"still":[1060],"patients,":[1070],"cost-effective.":[1080],"On":[1081],"strength":[1083],"reviewed":[1087],"here,":[1088],"against":[1117],"non-platinum-based":[1120],"compound,":[1121],"would":[1141],"reasonable":[1144],"option.":[1145]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139591966","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
